NCT05325164 2022-12-05
METHADOPT
Ottawa Hospital Research Institute
Phase 3 Withdrawn
Clinical Trials
5 trialsNCT00125294 2017-09-25
Sublingual Methadone for the Management of Cancer Breakthrough Pain
AHS Cancer Control Alberta
Phase 1 Completed
NCT00634010 2016-05-09
Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT02335398 2015-01-09
Development and Evaluation of a Methadone Protocol for Severe Chronic Pain Management
Mahidol University
Phase 4 Completed
NCT00525967 2007-09-06
Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain
Faculdade de Medicina do ABC
Phase 2/3 Unknown